Skip to results
Modify your search
NARROW
1-20 of 36
Authors: Matteo Bassetti
Journal Article
Antipseudomonal cephalosporins versus piperacillin/tazobactam or carbapenems for the definitive antibiotic treatment of Pseudomonas aeruginosa bacteraemia: new kids on the ICU block? Get access
Journal of Antimicrobial Chemotherapy, Volume 80, Issue 5, May 2025, Pages 1342–1353, https://doi.org/10.1093/jac/dkaf080
Published: 15 March 2025
Journal Article
Clinical characteristics, therapy and outcome of bloodstream infections caused by vancomycin-resistant enterococci: a multicentre clinical experience Get access
Journal of Antimicrobial Chemotherapy, Volume 80, Issue 5, May 2025, Pages 1241–1247, https://doi.org/10.1093/jac/dkaf055
Published: 25 February 2025
Journal Article
Impact of adequate empirical combination therapy on mortality in septic shock due to Pseudomonas aeruginosa bloodstream infections: a multicentre retrospective cohort study Get access
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 11, November 2024, Pages 2846–2853, https://doi.org/10.1093/jac/dkae296
Published: 03 September 2024
Journal Article
EDITOR'S CHOICE
Management of Clostridioides difficile infection: an Italian Delphi consensus
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 9, September 2024, Pages 2103–2118, https://doi.org/10.1093/jac/dkae179
Published: 13 July 2024
Journal Article
Triazole antifungal drug interactions—practical considerations for excellent prescribing
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 6, June 2024, Pages 1203–1217, https://doi.org/10.1093/jac/dkae103
Published: 17 April 2024
Journal Article
Lower blood levels of isavuconazole in critically ill patients compared with other populations: possible need for therapeutic drug monitoring
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 4, April 2024, Pages 835–845, https://doi.org/10.1093/jac/dkae037
Published: 15 February 2024
Journal Article
Mortality in KPC-producing Klebsiella pneumoniae bloodstream infections: a changing landscape
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 10, October 2023, Pages 2505–2514, https://doi.org/10.1093/jac/dkad262
Published: 22 August 2023
Journal Article
Triple antiviral treatment for COVID-19 in an immunocompromised patient
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 8, August 2023, Pages 2097–2099, https://doi.org/10.1093/jac/dkad159
Published: 25 May 2023
Journal Article
Ceftolozane/tazobactam for hospital-acquired/ventilator-associated bacterial pneumonia due to ESBL-producing Enterobacterales: a subgroup analysis of the ASPECT-NP clinical trial
Journal of Antimicrobial Chemotherapy, Volume 77, Issue 9, September 2022, Pages 2522–2531, https://doi.org/10.1093/jac/dkac184
Published: 04 July 2022
Journal Article
Current and future perspectives in the treatment of multidrug-resistant Gram-negative infections
Journal of Antimicrobial Chemotherapy, Volume 76, Issue Supplement_4, November 2021, Pages iv23–iv37, https://doi.org/10.1093/jac/dkab352
Published: 21 November 2021
Journal Article
Proactive therapeutic drug monitoring (TDM) may be helpful in managing long-term treatment with linezolid safely: findings from a monocentric, prospective, open-label, interventional study
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 12, December 2019, Pages 3588–3595, https://doi.org/10.1093/jac/dkz374
Published: 31 August 2019
Journal Article
An introduction to the future of echinocandin therapy
Journal of Antimicrobial Chemotherapy, Volume 73, Issue suppl_1, January 2018, Pages i2–i3, https://doi.org/10.1093/jac/dkx443
Published: 03 January 2018
Journal Article
What has changed in the treatment of invasive candidiasis? A look at the past 10 years and ahead
Journal of Antimicrobial Chemotherapy, Volume 73, Issue suppl_1, January 2018, Pages i14–i25, https://doi.org/10.1093/jac/dkx445
Published: 03 January 2018
Journal Article
Preface
Journal of Antimicrobial Chemotherapy, Volume 73, Issue suppl_1, January 2018, Page i1, https://doi.org/10.1093/jac/dkx442
Published: 03 January 2018
Journal Article
EDITOR'S CHOICE
Italian nationwide survey on Pseudomonas aeruginosa from invasive infections: activity of ceftolozane/tazobactam and comparators, and molecular epidemiology of carbapenemase producers
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 3, March 2018, Pages 664–671, https://doi.org/10.1093/jac/dkx453
Published: 05 December 2017
Journal Article
Invasive mould infections in the ICU setting: complexities and solutions
Journal of Antimicrobial Chemotherapy, Volume 72, Issue suppl_1, March 2017, Pages i39–i47, https://doi.org/10.1093/jac/dkx032
Published: 17 March 2017
Journal Article
EDITOR'S CHOICE
Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing urinary tract and intraabdominal infections in Europe: report from an antimicrobial surveillance programme (2012–15)
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 5, May 2017, Pages 1386–1395, https://doi.org/10.1093/jac/dkx009
Published: 06 February 2017
Journal Article
The current treatment landscape: candidiasis
Journal of Antimicrobial Chemotherapy, Volume 71, Issue suppl_2, November 2016, Pages ii13–ii22, https://doi.org/10.1093/jac/dkw392
Published: 07 November 2016
Journal Article
Might isoniazid plasma exposure be a valuable predictor of drug-related hepatotoxicity risk among adult patients with TB?
Journal of Antimicrobial Chemotherapy, Volume 71, Issue 5, May 2016, Pages 1323–1329, https://doi.org/10.1093/jac/dkv490
Published: 31 January 2016
Journal Article
Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort
Journal of Antimicrobial Chemotherapy, Volume 71, Issue 1, January 2016, Pages 196–207, https://doi.org/10.1093/jac/dkv288
Published: 03 October 2015
